Sartorius Stedim Biotech S.A. buy Barclays PLC
Start price
06.01.26
/
50%
€218.80
Target price
06.01.27
-
Performance (%)
-23.19%
Price
14:40
€168.05
Summary
This prediction is currently active. The prediction for Sartorius Stedim Biotech S.A. disappoints with a performance of -23.19%. This prediction currently runs until 06.01.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Sartorius Stedim Biotech S.A. | -0.335% | -0.335% |
| iShares Core DAX® | -0,48 % | -12,06 % |
| iShares Nasdaq 100 | -3,38 % | -5,13 % |
| iShares Nikkei 225® | -0,14 % | -12,63 % |
| iShares S&P 500 | -2,27 % | -5,05 % |
Comments by Barclays_PLC for this prediction
In the thread Sartorius Stedim Biotech S.A. diskutieren
Sartorius Stedim Biotech (OTCMKTS:SDMHF) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
Ratings data for SDMHF provided by MarketBeat